News from guardant health A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Apr 01, 2016, 09:00 ET Guardant Health To Present Liquid Biopsy Data From More Than 10,000 Patients At The AACR Annual Meeting

 Guardant Health®, the leader in comprehensive liquid biopsies, announced it will present data on more than 10,000 clinical...


Mar 29, 2016, 09:00 ET Guardant Health Announces Collaboration With Principia Biopharma To Use Guardant360® for Monitoring Patient Response and Tumor Evolution in FGFR Inhibitor Trials

 Guardant Health, the leader in liquid biopsy, announced a strategic collaboration with Principia Biopharma to monitor the response of patients...


Jan 07, 2016, 07:30 ET Guardant Health Secures Series D Financing to Expand the Reach of its Digital Sequencing™ Platform in Oncology

 Guardant Health, the leader in non-invasive cancer genomic sequencing, today announced it has completed a first closing on the majority of a...


Dec 02, 2015, 06:00 ET Guardant Health and Labco Quality Diagnostics (synlab Group) Announce Joint International Expansion

 Guardant Health, the leader in liquid biopsies, announced today that will accelerate the international commercialization of its...


Nov 09, 2015, 07:00 ET Guardant Health® and Collaborators Present Further Clinical Utility Data for Guardant360® at the AACR-NCI-EORTC International Conference On Molecular Targets and Cancer Therapeutics

 Guardant Health®, the leader in liquid biopsies, announced today the presentation of eight scientific posters by collaborators from...


Oct 20, 2015, 12:00 ET New studies show the power of comprehensive, non-invasive solid-tumor genomic testing with Guardant360®

 Guardant Health®, the leader in liquid biopsies, announced the publication of two peer-reviewed studies demonstrating the superior...


Sep 03, 2015, 09:00 ET Leading Cancer Centers to Present Clinical Utility Data For Guardant360 At IASLC's 16th World Conference on Lung Cancer in Denver Sept. 6-9

 Guardant Health®, the leader in liquid biopsies, announced today that five abstracts highlighting the performance and clinical utility of...


Aug 19, 2015, 09:00 ET Guardant Health and Flatiron Health to Develop Innovative Data Platform to Advance Precision Medicine for Cancer and Enhance Patient Care

 Guardant Health and Flatiron Health today announced a strategic collaboration to build a proprietary, cloud-based information platform...


Jun 24, 2015, 06:00 ET Guardant Health Partners With National Cancer Institute On First Ever Prospective Study To Implement cfDNA Genomic Profiling For Non-Small Cell Lung Cancer

Guardant Health®, the market leader in liquid biopsies, today announced that it has...


May 27, 2015, 06:00 ET Leading Cancer Centers To Present Clinical Utility Data for Guardant360® At ASCO

 Guardant Health® today announced that five abstracts submitted by the University of California, San Francisco; University of California,...


May 07, 2015, 06:00 ET Guardant Health Appoints Mort Minaee, Former Roche Senior Director, as VP of Regulatory Affairs

 Guardant Health®, the leader in biopsy-free tumor genomic testing, today announced the hire of Mort Minaee as Vice President of...


Apr 21, 2015, 06:00 ET Results Of Decision Impact Study Of Guardant360 In Metastatic Colorectal Cancer To Be Presented At AACR

Guardant Health® today announced new clinical utility data for its Guardant360® platform, which will be presented at the 2015 American...


Apr 20, 2015, 06:00 ET Guardant Health Presents Data on Biopsy-Free Tumor Genomic Profiling Of More Than 2000 Clinical Samples via Guardant360

 Guardant Health, the leader in cell-free tumor DNA testing, is presenting data today on its findings from more than 2,000 clinical samples...


Apr 08, 2015, 06:00 ET Guardant Health And Academic Collaborators To Present Clinical Utility Of Guardant360 For Solid Tumor Cancers

Guardant Health® today announced that six abstracts submitted by leading cancer institutes highlighting the performance and clinical utility...


Feb 03, 2015, 06:00 ET Guardant Health Secures Additional $50 Million Based On Strong Demand For Its Biopsy-Free Cancer Blood Test, Guardant360®

 Guardant Health today announced the completion of its Series C financing for approximately $50 million, bringing the Company's total funding...


Sep 15, 2014, 08:30 ET Guardant Health Receives Accreditation from the College of American Pathologists

 Guardant Health, a healthcare company focused on the development and commercialization of oncology diagnostic products, today announced that...


Sep 08, 2014, 08:30 ET Guardant Health Appoints Richard Lanman, M.D. as Chief Medical Officer

Guardant Health, a healthcare company focused on the development and commercialization of non-invasive tumor sequencing tests, today announced that...


Aug 26, 2014, 08:00 ET Guardant Health Named a 2015 Technology Pioneer by World Economic Forum

 Guardant Health, a healthcare company focused on the development and commercialization of oncology diagnostic products, has been recognized...


Aug 08, 2014, 05:30 ET Guardant Health to Present at the WedBush 2014 Life Sciences Management Access Conference

 Guardant Health, a life sciences company focused on the development and commercialization of oncology diagnostic products, announced today...


May 30, 2014, 08:00 ET Guardant Health Announces US Commercial Launch of Guardant360™: A Breakthrough Blood Test for Real-Time Cancer Patient Treatment Management

 Guardant Health, a healthcare company focused on the development and commercialization of oncology diagnostic products, announced today that...


Apr 22, 2014, 09:00 ET Guardant Health Announces $30 Million Series B Financing Led By Khosla Ventures

Guardant Health™ today announced the completion of its Series B financing, for over $30 million, to support the continued commercial...


Feb 12, 2014, 16:30 ET Guardant Health Releases Breakthrough Blood Test to Improve Cancer Treatment

 Guardant Health TM today announced the commercial availability of GUARDANT360TM, the first pan-cancer blood test that helps oncologists...